About this trial
This prospective, randomized, double-blind study evaluates the analgesic effectiveness of the ultrasound-guided Quadro-Iliac Plane (QIP) block in patients undergoing primary total hip arthroplasty. The QIP block is a recently described fascial plane block. Patients will be randomized to receive either a QIP block with local anesthetic or a sham block with saline. The primary outcome is 24-hour opioid consumption. Secondary outcomes include motor block, dermatomal sensory assessment, pain scores, rescue analgesic requirement, quality of recovery (QoR-15), and opioid-related side effects.
Eligibility criteria
Qualifiers
American Society of Anesthesiologists (ASA) classification I-III
Age between 18 and 80 years
Patients scheduled for elective primary total hip arthroplasty
Disqualifiers
Refusal to participate in the study
Allergy to local anesthetics or opioids
Known or suspected coagulopathy
Infection at the injection site
Trial design
Treatments tested in this trial
- Quadro-Iliac Plane (QIP) Block
- Sham Block